Profile
Robert H.
Rosen held several positions in the pharmaceutical industry, including President & Director at Heron Therapeutics, Global Head-Oncology at Bayer HealthCare Pharmaceuticals, and Vice President-Oncology Business Unit at Sanofi-Synthelabo.
He also served as an Independent Director at La Jolla Pharmaceutical Co. and NantKwest, Inc. Rosen was previously the Senior VP-Global Commercial Operations at Dendreon Corp.
He received his undergraduate degree from Northeastern University.
Former positions of Robert H. Rosen
| Companies | Position | End |
|---|---|---|
| LA JOLLA PHARMACEUTICAL COMPANY | Director/Board Member | 2022-08-21 |
| HERON THERAPEUTICS, INC. | President | 2019-02-04 |
| IMMUNITYBIO, INC. | Director/Board Member | 2015-06-21 |
| Scotia Nordic LLC | Corporate Officer/Principal | 2012-09-30 |
| DENDREON CORPORATION | Corporate Officer/Principal | 2012-02-29 |
Training of Robert H. Rosen
| Northeastern University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| HERON THERAPEUTICS, INC. | Health Technology |
| ODONATE, INC. | Health Technology |
| Private companies | 6 |
|---|---|
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
NantKwest, Inc.
 NantKwest, Inc. BiotechnologyHealth Technology NantKwest, Inc. engages in the research and development of immunotherapies. It uses natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. The company was founded by Gary N. Keller and Hans Georg Klingemannon October 7, 2002 and is headquartered in San Diego, CA. | Health Technology |
Bayer HealthCare Pharmaceuticals, Inc.
 Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bayer HealthCare Pharmaceuticals, Inc. manufactures pharmaceutical drugs. It offers pharmaceuticals and therapeutics in the areas of diagnostic imaging, hematology and cardiology, cancer, women's health and several other chronic diseases such as multiple sclerosis and Parkinson's disease. Bayer HealthCare Pharmaceuticals was founded in 1979 and is located in Wayne, NJ. | Health Technology |
| Sanofi-Synthelabo, Inc. | Health Technology |
| Scotia Nordic LLC |
- Stock Market
- Insiders
- Robert H. Rosen
